Cargando…
Ketorolac tromethamine alleviates IL-1β-induced chondrocyte injury by inhibiting COX-2 expression
Osteoarthritis (OA) is one of the most frequently diagnosed chronic diseases, and its prevalence is rising as life expectancy increases. The present study was designed to investigate the role of ketorolac tromethamine (KT) in OA by establishing an in vitro model in ATDC5 cells. The OA model was esta...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992376/ https://www.ncbi.nlm.nih.gov/pubmed/35411209 http://dx.doi.org/10.3892/etm.2022.11267 |